Peer Review History
| Original SubmissionOctober 7, 2022 |
|---|
|
PONE-D-22-27769Low Energy Multiple Blue light-emitting diode light Irradiation promotes melanin synthesis and induces DNA damage in B16F10 melanoma cellsPLOS ONE Dear Dr. Sakamoto, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Yi Cao Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "No The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This work was supported in part by Grants-in-Aid for Scientific Research and Education from the University of Tsukuba, Japan." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "No The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Manuscript is well presented. This study provides important information that helps better understand the effect blue light has on cells. The abstract is clear and describes the background, goals, and results of the paper well. As a general comment, the grammar could be improved throughout the manuscript before the final submission. My specific comments are below: INTRODUCTION 1) It may be beneficial to more clearly state the goals of this study. The last sentence of the introduction (page 4 line 51) states that “this study investigated the physiological effects of LED blue light on melanin synthesis in cells.” However, the paper examines many more things than just melanin synthesis. It also may be useful to provide more background in the introduction that will be later discussed in the paper, such as on wound healing, ROS, and DNA damage. 2) Page 3 Line 29 – The first sentence of the paper is confusing/ rather long, I would recommend to divide it into two sentences. 3) Page 3 line 39 – How is blue light significantly harmful to cells? Please provide more detail. METHODS 1) MTT is an enzyme assay and not a viability assay, despite it often being mistakenly used as a viability assay. This may account for the discrepancy seen when comparing with trypan blue. Either the authors need to label the MTT as an enzyme function assay or remove from the manuscript. 2) Page 5 line 75 – Please be consistent with the use of “day” and “d” throughout. 3) Page 6 line 96 – How many hours each day were the cells treated with blue light? 4) Page 6 line 101 – Please change “confluence” to “confluent.” RESULTS 1) Perhaps repeat the experiments in an additional cell line to ensure that these findings are not due to single cell line variability and are conserved across cell lines. 2) If blue light did not induce apoptosis, why was proliferation limited? The authors should add cell cycle experiments to determine blue light's effect on cell cycle. Additionally, is it possible that the cells were necrotic or fragmented and not picked up on flow cytometry? 3) Throughout the discussion and in the figure descriptions, authors did not say if findings were significant for numerous results (example – page 9 line 169, wound healing assay). Please always state if results are statistically significant. 4) How was the DNA damage assay selected? 5) Page 8 line 151 – Authors state “longer blue light irradiation times reduced cell viability.” Please clarify how exactly long cells were irradiated in this result. And was this reduction in cell viability statistically significant? 6) Page 9 line 159 (Fig 1C) – Clarify which assay was used in the figure description. 7) Page 10 line 181– The first sentence in the ROS paragraph might fit better in the introduction. 8) Page 10 line 185 – Was intracellular ROS significantly increased? 9) Page 10 line 190 – State what kit was used to measure DNA damage. 10) Page 11 line 206 – Again, the first couple sentences of this paragraph belongs in the introduction, as this is the background/ reasoning for conducting these experiments 11) Page 11 line 209 – Authors state, “irradiation also slightly promoted melanin synthesis.” What does “slightly” mean? DISCUSSION/ CONCLUSION I believe this section could discuss the results of the experiments more. What are some possible reasons why low energy blue light inhibits migration? What is the significance of low energy blue light causing increased ROS and DNA damage to our cells? What are some potential reasons the author’s study found that blue light inhibits cell migration, when it is reported in other studies that ROS promotes cell migration? How do the results of this study compare to other studies? The work here is very nice, and similar to the works referenced in manuscript reference #20 by Mamalis et al. Please note how you distinguished your works. The authors also need to add more to the limitations section and how they mitigated against these challenges. Additionally, the conclusion of the paper mostly restates the results. Are there any other final thoughts or conclusions that the authors would like readers to take away from this paper? FIGURES Figure 1C – This graph does not show if the results are statistically significant. Reviewer #2: In this paper, low energy and multiple blue light irradiations were used to promote melanin synthesis and DNA damage in mouse melanoma B16-F10 cells, which indicate that blue light is harmful to cells in the body. But on the whole, the work is actually routine without deep investigation, and the experimental design lacks completeness, meanwhile the significance and novelty of this work are not enough. Specific comments: 1. Cancer cells endure higher oxidative stress than normal cells due to their malignant transformation and metabolic disturbance. Mouse melanoma B16-F10 was selected for in vitro experiments to demonstrates the damage of blue light for cells in the body. The authors should indicate whether normal cells after blue light irradiation also exhibit increased ROS levels consistent with cancer cells. 2. UV and blue light have limited penetration depth in vivo because of substantial absorption by skin and underlying soft tissues. There are no enough animal experiments to verify that similar physiological effect also exhibit in vivo in this work. 3. Growing evidence indicated that blue light induce ROS generation for retina cells injury or DNA damage, the significance and novelty of this work are not enough. 4. Phenol red contained cell medium would affect the modulated effects of blue light to cells. In this paper, there are no elaborate the experimental details when blue light irradiation was performed. 5. In Figure 1D, Figure 3A and 3C, the fluorescence images of cells apoptosis, ROS generation and DNA damage are not clear enough. And the authors should provide the bright field images to demonstrated that no significant difference in cells number. 6. In Figure 2, there is no enough evidence supported that B16-F10 cells migrated after blue light irradiation. The author should explain more in detail. 7. In Figure 4, mRNA changes of several factors (TYR, TRP-1, TRP-2, mitf) were detected to show the reasons for melanin synthesis in B16-F10 cells. However, the protein level-changes are not being demonstrated, more tests and results should be shown here. Reviewer #3: The reported work addresses the important and increasingly studied issue of the effect of visible light, and in particular blue light, on skin. Important contributions have been published in the field in the recent years. The novelty in the work by Zhou et al, performed on a melanocyte cell line, is the use of a semi-chronic exposure pattern with repeated irradiation at low fluences. It seems also that the authors used a 470 nm source, namely photons of lower energy than in other works. The text is yet not clear on this aspect. The emission spectrum of the lamp should be provided or at least described. The expression “low energy” should be rephrased because it can be understood as low energy photons or low fluence. Using this irradiation protocol, the authors studied the phototoxicity of blue light, the induction of reactive oxygen species, the genotoxicity and the melanin synthesis. Major improvements have to be made on all these aspects. The phototoxicity is studied by a MTT viability test, a trypan blue survival assay and cell counting. Exposures last 1 h or 2 h per day for 1, 2 or 3 days. Viability and cell counting lead to the same conclusion that the exposure protocol exhibit to a strong phototoxicity. In contrast, the trypan blue assay shows no impact on cell survival. These data are difficult to reconcile. The observation of a strong phototoxicity is a key point for the interpretation of all the other studied endpoints. It is worth mentioning that no apoptosis is detected; but no positive control is used that could establish the reliability of the technique used. The next investigated response is a wound healing assay reflecting proliferation. The authors failed to observe migration of cells in the scratched area. The strong phototoxicity could well explain this result since dying cell will not replicate. The authors actually report a decrease in cell area, which shows more a cell death than a lack of migration. The authors then report induction of ROS and formation of DNA damage revealed as double-strand breaks through the gamma-H2AX assay. Again, the fact that cells are dying in large proportion should make the authors more careful in their conclusion. They should also correct the discussion of DNA damage inducing oxidative stress. The succession of events is actually opposite. The last part of the manuscript devoted to induction of melanogenesis by blue light is more convincing as it involves both quantification of melanin and assessment of the expression of a series of relevant genes. In summary, this manuscript report some interesting results but the discussions and the conclusions have to be much more carefully made because of the phototoxicity under the irradiation condition. The authors also may want to be less alarmist on the health impact of their findings. Repeated reference to ocular toxicity is out of the scope of this study on skin. There is a big difference between cells in a plate and the human body. In that respect, the abstract should be rewritten with more scientific input and presentation of the present study. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-27769R1Low Energy Multiple Blue light-emitting diode light Irradiation promotes melanin synthesis and induces DNA damage in B16F10 melanoma cellsPLOS ONE Dear Dr. Sakamoto, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Please consider the comments from reviewer 1 ============================== Please submit your revised manuscript by Feb 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Yi Cao Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Title: Low Energy Multiple Blue light-emitting diode light Irradiation promotes melanin synthesis and induces DNA damage in B16F10 melanoma cells Authors: Siqi ZHOU, Ryusuke YAMADA, Kazuichi Sakamoto This paper provides important information that helps better understand the effect blue light has on cells. The abstract is clear and describes the background, goals, and results of the paper well. As a general comment, the English grammar needs to be improved throughout the manuscript before the final submission. My specific comments are below: Introduction 1. It may be helpful to provide further background and statistics on the prevalence of screen use in recent years, especially due to COVID. It would also be helpful to clearly specify what wavelength and energy of blue light is present in most daily use screens. 2. Authors discuss red light in the second paragraph of the introduction. It would be helpful to provide further background on the effect red light has on cellular proliferation, ROS, and DNA damage, as these are things this paper is studying. Methods 1. Please specific the light irradiation protocol (ex/ how many hours of irradiation per day) in the “Light irradiation” section of the introduction. 2. What plating density was used for the light irradiation? 3. Please specify how long after light irradiation each assay was performed. Discussion 1. What is the significance of the fact that blue light inhibited cellular proliferation, but did not cause apoptosis? (page 14) 2. Perhaps more clearly discuss why the MTT assay showed reduced cell enzymatic activity, but the trypan blue assay shows no impact on cell survival in the discussion. 3. What is the significance of blue light inhibiting cell migration? (page 15) 4. What do authors mean when they state “intracellular ROS and DNA damage immediately occurred after blue light irradiation, and there was no significant change after three days irradiation? (page 16 line 327). In the methods and results, authors only discussed that immediately after blue light irradiation, ROS production and DMA damage was increased. 5. In the abstract, authors state “low energy density blue light multiple exposure is still harmful to our cells even though the effect is lower than short wavelength high energy blue light.” Please cite evidence of this and discuss in the discussion. Figures 1. Please define all abbreviations used in figures in the key (ex/ NL, B1h, B2h) Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Low Energy Multiple Blue light-emitting diode light Irradiation promotes melanin synthesis and induces DNA damage in B16F10 melanoma cells PONE-D-22-27769R2 Dear Dr. Sakamoto, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yi Cao Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-27769R2 Low Energy Multiple Blue light-emitting diode light Irradiation promotes melanin synthesis and induces DNA damage in B16F10 melanoma cells Dear Dr. Sakamoto: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Yi Cao Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .